StockWatch
·
Specialty Chemicals
Board Meeting12 Nov 2026, 01:47 pm

SK Minerals Q2 FY27: standalone PAT falls 30% YoY to ₹3.78 Cr as costs squeeze margins

AI Summary

SK Minerals & Additives posted standalone Q2 FY27 (quarter ended 30-Sep-26) revenue from operations of ₹74.44 Cr, down 1.7% year-on-year from ₹75.72 Cr, while standalone PAT fell 29.6% YoY to ₹3.78 Cr from ₹5.37 Cr. Net profit margin compressed to 5.05% from 7.07% a year ago. Sequentially the picture looks better — revenue rose 15.5% and PAT 2.0% over Q1 FY27 (₹64.45 Cr / ₹3.70 Cr) — but per our YoY-anchored convention that QoQ pickup reads as a partial recovery within a down year, not the story. There is no analyst coverage of this SME-platform stock (confirmed via search — zero brokerage estimates found), so vsStreet is unknown; there is also no company press release beyond the board-outcome letter to react to. The margin compression is cost-driven, not revenue-driven: cost of materials consumed rose ~38% YoY (₹15.03 Cr vs ₹10.88 Cr) and employee benefit expense rose ~73% (₹2.59 Cr vs ₹1.50 Cr) as the company scales in-house manufacturing capacity. Finance costs climbed ~56% YoY (₹2.17 Cr vs ₹1.39 Cr) on short-term borrowings that grew 33% since March-26 (to ₹111.71 Cr) to fund a 54.5% build-up in inventories (₹38.40 Cr) and higher receivables — working-capital strain from the capacity ramp. Depreciation rose ~33% YoY as capitalised capex (gross block up to ₹27.52 Cr from ₹22.74 Cr at FY26-end, with capital work-in-progress fully capitalised) came onstream. This cuts against the prior concall's guidance (May-26) of "continued strong momentum" in FY27 and margins improving as in-house manufacturing of products like halogen-free flame retardants scales — on this quarter's YoY numbers that improvement has not yet shown up, so guidance reads as missed for the quarter, even as the underlying capex programme continues: the company allotted 54.93 lakh convertible warrants on 24-Aug-26 for ₹54.52 Cr (25% upfront, of a ₹218.07 Cr total raise) earmarked for the stated "Expansion and Growth" objective, of which none had been deployed as of 30-Sep-26 (₹185.36 Cr still unutilised). Separately, the quarter marks the company's first-ever export sales of ₹8.24 Cr (nil in both the year-ago and immediately preceding quarters), a new revenue stream alongside the ₹59.9 lakh food-additives order bagged on 28-Oct-26 (after quarter-end) and board-approved director/secretarial-auditor changes on 1-Oct-26. Going into Q3 FY27, the key test is whether the capacity expansion (targeting 18,000 MT over 12-18 months per management's prior framing) begins translating the QoQ revenue recovery into YoY growth and margin expansion, or whether rising finance and depreciation costs continue to outpace operating leverage.

Key Highlights

  • Standalone revenue from operations ₹74.44 Cr, down 1.7% YoY (₹75.72 Cr) but up 15.5% QoQ (₹64.45 Cr)
  • Standalone PAT ₹3.78 Cr, down 29.6% YoY (₹5.37 Cr), up 2.0% QoQ (₹3.70 Cr)
  • Net profit margin compressed to 5.05% from 7.07% YoY on higher material, employee, finance and depreciation costs
  • Basic EPS ₹3.11 (vs ₹5.96 YoY); diluted EPS lower at ₹2.64 due to dilution from 54.93 lakh convertible warrants
  • First-ever export sales of ₹8.24 Cr this quarter vs nil in the year-ago and prior quarters
  • Raised ₹54.52 Cr (25% upfront of a ₹218.07 Cr preferential warrant issue, Aug-26) for capacity expansion; ₹185.36 Cr still unutilised
  • Short-term borrowings up 33% to ₹111.71 Cr since Mar-26, funding a 54.5% rise in inventories to ₹38.40 Cr